dimethylphenylpiperazinium iodide has been researched along with Acute Lung Injury in 1 studies
Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qi, F | 1 |
| Duan, C | 1 |
| Chen, T | 1 |
| Li, F | 1 |
| Zhang, J | 1 |
1 other study available for dimethylphenylpiperazinium iodide and Acute Lung Injury
| Article | Year |
|---|---|
DMPP attenuates lipopolysaccharide-induced lung injury by inhibiting glycocalyx degradation through activation of the cholinergic anti-inflammatory pathway.
Topics: Acute Lung Injury; Animals; Cytokines; Dimethylphenylpiperazinium Iodide; Glycocalyx; Iodides; Lipop | 2023 |